About this trial
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Males and females ages 18-80 years old.
Patients with recent corneal abrasion and no signs of infection in the examination
Patients with lagophthalmos
Normal Controls
Disqualifiers
Individuals with adhesive or tape allergies.
Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking)
Individuals with eye infections
Trial design
Single group
Treatments tested in this trial
temporary magnetic system for tarsorrhaphy (MST)
Devicecutting-edge technology has produced smaller magnets with stronger magnetic fields, prompting experts to revisit the use of magnets to facilitate eyelid closure
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with success of a temporary magnetic system for tarsorrhaphy
Use of a temporary magnetic system for tarsorrhaphy (MST) to provide adequate closure of the eyes for ultimate use in conditions causing lagophthalmos (a disorder in eyelid closure)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.